AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Macsita-MXR 100/1000 Tablet

Prescription Icon
Prescription Required

Marketer

Macleods Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (100mg) + Metformin (1000mg)

Overview Macsita-MXR 100/1000 Tablet

Diabex Duo 100/1000 tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent serious diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabex Duo 100/1000 may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Consuming the tablets with food minimizes gastrointestinal upset. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Adherence to your prescribed diet and exercise plan is crucial for successful diabetes management. Commonly reported side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia, especially when used with insulin or sulfonylureas, is a potential adverse effect requiring prompt recognition and management. This medication is not universally suitable. Prior to commencing treatment, disclose any history of renal, hepatic, or cardiac disease, pancreatic disorders, or significant alcohol consumption to your physician. Pregnant or lactating women should seek medical counsel. Inform your doctor of all other medications you are taking to ensure compatibility and safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose levels throughout therapy.

Uses of Macsita-MXR 100/1000 Tablet

Managing type 2 diabetes

Major Benefits of Macsita-MXR 100/1000 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Macsita-MXR 100/1000 Tablet should be administered with a meal.

Common Side effects of Macsita-MXR 100/1000 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Macsita-MXR 100/1000 Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Macsita-MXR 100/1000 Tablet whole; avoid chewing, crushing, or fracturing. Administer this medication with food.

How Macsita-MXR 100/1000 Tablet works:

Macsita-MXR 100/1000 tablets combine sitagliptin and metformin to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use and Macsita-MXR 100/1000 Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Macsita-MXR 100/1000 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Macsita-MXR 100/1000 tablets while breastfeeding is likely inadvisable. Available human data indicates a potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Macsita-MXR 100/1000 Tablet cautiously, potentially requiring dosage modification. Consult a physician for guidance. The medication is contraindicated in individuals with severe kidney disease. Regular kidney function monitoring is recommended during treatment.

LiverLiverUNSAFE

The use of Macsita-MXR 100/1000 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Macsita-MXR 100/1000 Tablet :

Should you forget a Macsita-MXR 100/1000 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Macsita-MXR 100/1000 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Macsita-MXR 100/1000 Tablet

Macsita-MXR 100/1000 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Macsita-MXR 100/1000 Tablets can lead to Vitamin B12 deficiency by interfering with its absorption. This deficiency may cause anemia, nerve damage (manifested as numbness, tingling in extremities, weakness, and gait problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental Vitamin B12 is recommended at least annually by some researchers.
Macsita-MXR 100/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Macsita-MXR 100/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Macsita-MXR 100/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA). This rare side effect necessitates avoiding metformin in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Macsita-MXR 100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Macsita-MXR 100/1000 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Macsita-MXR 100/1000 Tablets are contraindicated in patients with allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 100/1000 tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Macsita-MXR 100/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-Associated Lactic Acidosis). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 100/1000 Tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency can cause anemia, nerve damage (manifesting as numbness, tingling in extremities, weakness, and balance problems), and urinary issues, along with cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Macsita-MXR 100/1000 tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Macsita-MXR 100/1000 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Macsita-MXR 100/1000 Tablet is contraindicated in patients with allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Macsita-MXR 100/1000 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Macsita-MXR 100/1000 (containing metformin) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Macsita-MXR 100/1000 Tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication safely and ensure it's inaccessible to children, pets, and others.
Macsita-MXR 100/1000 Tabl...
156